bpc-157 tb-500 benefits Yes, is the world's most hyped peptide these days. But . . . does it REALLY deliver on all that Wolverine-ish talk? World's Strongest Man @mitchellhooper and @ebenezersamuel23 break it down 10 questions to ask your

CLASSIFICATION: SYNTHETIC PEPTIDE (REPAIR & RECOVERY) ACTIVE SUBSTANCE: THYMOSIN BETA-4 FORM: 2 ML VIAL x 5 MG (LYOPHILIZED POWDER) ACTIVE HALF-LIFE: 2.5-3 DAYS DOSAGE: MEN 7.66 MG/WEEK ACNE: NO WATER RETENTION: NO HIGH BLOOD PRESSURE (HBP): NO HEPATOTOXICITY: NO AROMATIZATION: NO MANUFACTURER: DRAGON PHARMA LABORATORY TESTED : VIEW LAB RESULTS CLASSIFICATION: NOOTROPIC PEPTIDE ACTIVE SUBSTANCE: SELANK FORM: 2 ML VIAL x 10 MG (LYOPHILIZED POWDER) ACTIVE HALF-LIFE: ~ 2-3 HOURS DOSAGE: MEN 250-500 MCG/DAY ACNE: NO WATER RETENTION: MINIMAL HIGH BLOOD PRESSURE (HBP): NO HEPATOTOXICITY: NO AROMATIZATION: NO MANUFACTURER: DRAGON PHARMA LABORATORY TESTED : VIEW LAB RESULTS CLASSIFICATION: SYNTHETIC MELANOCORTIN PEPTIDE ACTIVE SUBSTANCE: MELANOTAN 2 FORM: 2 ML VIAL x 10 MG (LYOPHILIZED POWDER) ACTIVE HALF-LIFE: ~ 3036 HOURS DOSAGE: 0.251 MG/DAY (LOADING), THEN 0.51 MG EVERY 23 DAYS (MAINTENANCE) ACNE: NO WATER RETENTION: NO HIGH BLOOD PRESSURE (HBP): NO HEPATOTOXICITY: NO AROMATIZATION: NO MANUFACTURER: DRAGON PHARMA LABORATORY TESTED : VIEW LAB RESULTS CLASSIFICATION: NOOTROPIC PEPTIDE ACTIVE SUBSTANCE: SEMAX FORM: 2 ML VIAL x 5 MG (LYOPHILIZED POWDER) ACTIVE HALF-LIFE: 2-3 HOURS DOSAGE: MEN 200-600 MCG/DAY ACNE: NO WATER RETENTION: NO HIGH BLOOD PRESSURE (HBP): NO HEPATOTOXICITY: NO AROMATIZATION: NO MANUFACTURER: DRAGON PHARMA LABORATORY TESTED : VIEW LAB RESULTS CLASSIFICATION: BODY PROTECTING COMPOUND ACTIVE SUBSTANCE: PENTADECAPEPTIDE FORM: 2 ML VIAL x 5 MG (LYOPHILIZED POWDER) ACTIVE HALF-LIFE: ~ 4-6 HOURS DOSAGE: 200-500 MCG/DAY ACNE: NOT REPORTED WATER RETENTION: NONE HIGH BLOOD PRESSURE (HBP): NO KNOWN IMPACT HEPATOTOXICITY: NONE AROMATIZATION: DOES NOT AROMATIZE MANUFACTURER: DRAGON PHARMA LABORATORY TESTED : VIEW LAB RESULTS CLASSIFICATION: NUTRITIONAL SUPPLEMENT

Used needles and syringes must go into an approved sharps container

Emerg Med J 25:3337 Stambolija V, Stambolija TP, Holjevac JK, Murselovic T, Radonic J, Duzel V, Duplancic B, Uzun S, Zivanovic-Posilovic G, Kolenc D, Drmic D (2016) BPC 157: the counteraction of succinylcholine, hyperkalemia, and arrhythmias

and critically human PK data (unavailable because no completed clinical trials have been published)